MetaCap

Ultragenyx Pharmaceutical Insider Trades

NASDAQ: RAREHealth CareBiotechnology: Pharmaceutical PreparationsUSD

16.48-0.74 (-4.30%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
28 · $3.81M
Shares bought / sold
0 / 164.52K
Net activity
Net selling $3.8 million

Ultragenyx Pharmaceutical insider activity

Over the last 12 months, Ultragenyx Pharmaceutical insiders reported 52 transactions on SEC Form 4: 0 open-market purchases and 28 sales. Insiders bought $0 and sold $3.8 million worth of stock, for net insider selling of $3.8 million. The largest seller was KAKKIS EMIL D, with $1.2 million in reported sales.

The most recent filing shows Horn Howard (Chief Financial Officer) selling 7,066 shares at $15.27 on Oct 15, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put RARE's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

RARE insider transactions

Ultragenyx Pharmaceutical insider transactions
DateInsiderTypeSharesValueFiling
Oct 15, 2026Horn HowardChief Financial OfficerSale7,066$107.90KForm 4
Sep 15, 2026Huizenga Theodore AlanSVP, Chief Accounting OfficerSale1,283$17.41KForm 4
Sep 3, 2026Huizenga Theodore AlanSVP, Chief Accounting OfficerSale161$2.25KForm 4
Aug 3, 2026Horn HowardChief Financial OfficerSale4,696$117.02KForm 4
Aug 3, 2026Parschauer Karah HerdmanEVP and Chief Legal OfficerSale1,900$47.35KForm 4
Jul 1, 2026Horn HowardChief Financial OfficerSale4,698$155.64KForm 4
Jun 15, 2026Parschauer Karah HerdmanEVP and Chief Legal OfficerSale1,899$46.75KForm 4
Jun 15, 2026Sanders Corazon (Corsee) D.DirectorSale2,000$50.10KForm 4
Jun 1, 2026Horn HowardChief Financial OfficerSale4,653$110.60KForm 4
May 18, 2026SULIMAN SHEHNAAZDirectorSale5,740$144.19KForm 4
May 14, 2026WELCH DANIEL GDirectorAward7,751—Form 4
May 14, 2026NARACHI MICHAELDirectorAward7,751—Form 4
May 14, 2026Sanders Corazon (Corsee) D.DirectorAward7,751—Form 4
May 14, 2026Dunsire DeborahDirectorAward7,751—Form 4
May 14, 2026SULIMAN SHEHNAAZDirectorAward7,751—Form 4
May 14, 2026Fust Matthew KDirectorAward7,751—Form 4
May 14, 2026Ray AmritDirectorAward7,751—Form 4
May 5, 2026Crombez EricEVP and Chief Medical OfficerSale344$8.59KForm 4
May 1, 2026Horn HowardChief Financial OfficerSale4,683$116.61KForm 4
Apr 22, 2026Huizenga Theodore AlanSVP, Chief Accounting OfficerAward20,241—Form 4
Apr 16, 2026Crombez EricEVP and Chief Medical OfficerAward34,674—Form 4
Apr 16, 2026Harris ErikEVP & Chief Commercial OfficerAward28,895—Form 4
Apr 16, 2026Parschauer Karah HerdmanEVP and Chief Legal OfficerAward28,895—Form 4
Apr 16, 2026Horn HowardChief Financial OfficerAward34,674—Form 4
Apr 16, 2026Pinion John RichardSee RemarksAward23,116—Form 4
Apr 16, 2026Huang Dennis KarlSee RemarksAward23,116—Form 4
Apr 16, 2026KAKKIS EMIL DPresident & CEOAward76,745—Form 4
Apr 1, 2026Horn HowardChief Financial OfficerSale4,683$98.20KForm 4
Mar 10, 2026Parschauer Karah HerdmanEVP and Chief Legal OfficerSale3,508$79.53KForm 4
Mar 6, 2026Parschauer Karah HerdmanEVP and Chief Legal OfficerSale6,018$128.79KForm 4
Mar 3, 2026Horn HowardChief Financial OfficerSale1,635$36.62KForm 4
Mar 2, 2026Crombez EricEVP and Chief Medical OfficerSale7,029$160.26KForm 4
Mar 2, 2026Horn HowardChief Financial OfficerSale3,119$70.30KForm 4
Mar 2, 2026Horn HowardChief Financial OfficerSale5,290$120.61KForm 4
Mar 2, 2026Huizenga Theodore AlanSVP, Chief Accounting OfficerSale1,632$37.21KForm 4
Mar 2, 2026Huizenga Theodore AlanSVP, Chief Accounting OfficerTax withholding148$3.46KForm 4
Mar 2, 2026Huang Dennis KarlSee RemarksTax withholding999$23.37KForm 4
Mar 2, 2026Harris ErikEVP & Chief Commercial OfficerSale10,539$240.29KForm 4
Mar 2, 2026Pinion John RichardSee RemarksSale10,029$228.66KForm 4
Mar 2, 2026Parschauer Karah HerdmanEVP and Chief Legal OfficerSale8,135$185.48KForm 4
Mar 2, 2026KAKKIS EMIL DPresident & CEOSale54,404$1.24MForm 4
Mar 1, 2026Crombez EricEVP and Chief Medical OfficerAward11,643—Form 4
Mar 1, 2026Horn HowardChief Financial OfficerAward6,143—Form 4
Mar 1, 2026Huang Dennis KarlSee RemarksAward11,137—Form 4
Mar 1, 2026Harris ErikEVP & Chief Commercial OfficerAward11,643—Form 4
Mar 1, 2026Pinion John RichardSee RemarksAward11,137—Form 4
Mar 1, 2026Parschauer Karah HerdmanEVP and Chief Legal OfficerAward11,137—Form 4
Mar 1, 2026KAKKIS EMIL DPresident & CEOAward71,177—Form 4
Feb 2, 2026Horn HowardChief Financial OfficerSale3,061$72.12KForm 4
Jan 2, 2026Horn HowardChief Financial OfficerSale3,150$71.95KForm 4
Dec 29, 2025Huizenga Theodore AlanSVP, Chief Accounting OfficerSale85$2.92KForm 4
Dec 10, 2025Horn HowardChief Financial OfficerSale3,081$112.09KForm 4
Oct 13, 2025Horn HowardChief Financial OfficerSale7,942$250.25KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related